BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 9500975)

  • 1. Catalytically self-sufficient P450 CYP102 (cytochrome P450 BM-3): resonance Raman spectral characterization of the heme domain and of the holoenzyme.
    Hudeèek J; Baumruk V; Anzenbacher P; Munro AW
    Biochem Biophys Res Commun; 1998 Feb; 243(3):811-5. PubMed ID: 9500975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Domains of the catalytically self-sufficient cytochrome P-450 BM-3. Genetic construction, overexpression, purification and spectroscopic characterization.
    Miles JS; Munro AW; Rospendowski BN; Smith WE; McKnight J; Thomson AJ
    Biochem J; 1992 Dec; 288 ( Pt 2)(Pt 2):503-9. PubMed ID: 1334408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural similarities and differences of the heme pockets of various P450 isoforms as revealed by resonance Raman spectroscopy.
    Hudecek J; Anzenbacherová E; Anzenbacher P; Munro AW; Hildebrandt P
    Arch Biochem Biophys; 2000 Nov; 383(1):70-8. PubMed ID: 11097178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectral properties of the oxyferrous complex of the heme domain of cytochrome P450 BM-3 (CYP102).
    Bec N; Anzenbacher P; Anzenbacherová E; Gorren AC; Munro AW; Lange R
    Biochem Biophys Res Commun; 1999 Dec; 266(1):187-9. PubMed ID: 10581187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probing inter-domain electron transfer in a model flavocytochrome P-450.
    Munro AW; Daff SN; Turner KL; Chapman SK
    Biochem Soc Trans; 1997 Nov; 25(4):S629. PubMed ID: 9450057
    [No Abstract]   [Full Text] [Related]  

  • 6. Affinity isolation and characterization of cytochrome P450 102 (BM-3) from barbiturate-induced Bacillus megaterium.
    Black SD; Linger MH; Freck LC; Kazemi S; Galbraith JA
    Arch Biochem Biophys; 1994 Apr; 310(1):126-33. PubMed ID: 8161195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the interactions of cytochrome b5 with flavocytochrome P450 BM3 and its domains.
    Noble MA; Girvan HM; Smith SJ; Smith WE; Murataliev M; Guzov VM; Feyereisen R; Munro AW
    Drug Metab Rev; 2007; 39(2-3):599-617. PubMed ID: 17786641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deflavination of cytochrome P450 BM3 by treatment with guanidinium chloride.
    Munro AW; Coggins JR; Lindsay JG; Kelly S; Price NC
    Biochem Soc Trans; 1996 Feb; 24(1):19S. PubMed ID: 8674659
    [No Abstract]   [Full Text] [Related]  

  • 9. Resonance Raman spectroscopic studies on intact cytochrome P450 BM3.
    Munro AW; Lindsay JG; Coggins JR; MacDonald I; Smith WE; Rospendowski BN
    Biochem Soc Trans; 1994 Feb; 22(1):54S. PubMed ID: 8206282
    [No Abstract]   [Full Text] [Related]  

  • 10. Cobaltocene-mediated catalytic monooxygenation using holo and heme domain cytochrome P450 BM3.
    Udit AK; Arnold FH; Gray HB
    J Inorg Biochem; 2004 Sep; 98(9):1547-50. PubMed ID: 15337607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of replacement of ferriprotoporphyrin IX in the haem domain of cytochrome P-450 BM-3 on substrate binding and catalytic activity.
    Modi S; Primrose WU; Lian LY; Roberts GC
    Biochem J; 1995 Sep; 310 ( Pt 3)(Pt 3):939-43. PubMed ID: 7575430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression, purification, and characterization of Bacillus subtilis cytochromes P450 CYP102A2 and CYP102A3: flavocytochrome homologues of P450 BM3 from Bacillus megaterium.
    Gustafsson MC; Roitel O; Marshall KR; Noble MA; Chapman SK; Pessegueiro A; Fulco AJ; Cheesman MR; von Wachenfeldt C; Munro AW
    Biochemistry; 2004 May; 43(18):5474-87. PubMed ID: 15122913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the linker region connecting the reductase and heme domains in cytochrome P450BM-3.
    Govindaraj S; Poulos TL
    Biochemistry; 1995 Sep; 34(35):11221-6. PubMed ID: 7669780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMR studies of substrate binding to cytochrome P450 BM3: comparisons to cytochrome P450 cam.
    Modi S; Primrose WU; Boyle JM; Gibson CF; Lian LY; Roberts GC
    Biochemistry; 1995 Jul; 34(28):8982-8. PubMed ID: 7619797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P450BM-3: reduction by NADPH and sodium dithionite.
    Peterson JA; Boddupalli SS
    Arch Biochem Biophys; 1992 May; 294(2):654-61. PubMed ID: 1567220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probing electron transfer in flavocytochrome P-450 BM3 and its component domains.
    Munro AW; Daff S; Coggins JR; Lindsay JG; Chapman SK
    Eur J Biochem; 1996 Jul; 239(2):403-9. PubMed ID: 8706747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation of flavin semiquinone during the reduction of P450 BM3 reductase domain with NADPH.
    Munro AW; Coggins JR; Lindsay JG; Daff S; Chapman SK
    Biochem Soc Trans; 1996 Feb; 24(1):18S. PubMed ID: 8674656
    [No Abstract]   [Full Text] [Related]  

  • 18. Functional interactions in cytochrome P450BM3: flavin semiquinone intermediates, role of NADP(H), and mechanism of electron transfer by the flavoprotein domain.
    Murataliev MB; Klein M; Fulco A; Feyereisen R
    Biochemistry; 1997 Jul; 36(27):8401-12. PubMed ID: 9204888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Redox characterisation of flavocytochrome P-450 BM3 from Bacillus megaterium.
    Munro AW; Daff SN; Turner KL; Chapman SK
    Biochem Soc Trans; 1997 Nov; 25(4):S628. PubMed ID: 9450056
    [No Abstract]   [Full Text] [Related]  

  • 20. Obligatory intermolecular electron-transfer from FAD to FMN in dimeric P450BM-3.
    Kitazume T; Haines DC; Estabrook RW; Chen B; Peterson JA
    Biochemistry; 2007 Oct; 46(42):11892-901. PubMed ID: 17902705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.